publication date: Mar. 25, 2016
20160325 - Mar. 25, 2016
ISSUE 12 – MARCH 25, 2016PDF



Clifford Hudis Named CEO of ASCO

Clifford Hudis was named CEO of the American Society of Clinical Oncology.

Hudis, who served as ASCO president in 2013 and 2014, is chief of Breast Medicine Service as well as vice president for government relations and chief advocacy officer at Memorial Sloan Kettering Cancer Center.

Hudis, 56, will start the job at the society’s headquarters in Alexandria, Va., June 27. He will succeed Allen Lichter, who is retiring after having held that job for ten years.

 

NEJM Editors: There Will Be No Clarification For Disputed Power Morcellation Story

The New England Journal of Medicine said it stands by the story that has triggered investigations of a potential breach of patient confidentiality.

In a paper that criticized FDA’s regulatory actions that effectively ended power morcellation in gynecology, Lisa Rosenbaum, an NEJM national correspondent, made a statement that some readers interpreted as suggesting that she had access to confidential patient information (The Cancer Letter, March 18).

Rosenbaum is a cardiologist at Brigham & Women’s Hospital, the institution where Amy Reed—a patient who brought national attention to the harm associated with the procedure—underwent her ill-fated hysterectomy. 

Slamming the Door

Part IX – “Furnituregate”

I first heard something about a red sofa that cost an impressive amount of money soon after I started to cover the controversy at the Cancer Prevention and Research Institute of Texas.

The sofa, I was told, was to be purchased with MD Anderson funds for the office of Lynda Chin. I wanted to look into it, but I want to look into many things, and some take precedence over others. This seemed to be fun, but it was undeniably trivial.

The sofa in question was intended for the same entity CPRIT was being asked to fund. Had I been able to get it through my thick skull that the furniture was a part of the same story that was causing the ungluing of CPRIT, I would have filed my freedom of information requests sooner.

NCCN Launches Evidence Blocks as Part of its Guidelines

The National Comprehensive Cancer Network launched its value tool, NCCN Evidence Blocks, which will be presented at its annual conference, March 31 to April 2.

NCCN has published two additional resources since its 2015 meeting: the NCCN Framework and the NCCN Quick Guide Series for patients.

In Brief
  • Maha Hussain joins Northwestern University Lurie Cancer Center

  • Jean-Yves Douillard appointed chief medical officer of ESMO

  • Karmanos promotes five scientific staff members

  • Jennifer Pietenpol receives award from T.J. Martell Foundation
  • Pediatric Oncologist Dennis Hughes pleads guilty to collecting child pornography

  • American Cancer Society receives $1.58 million grant from The Merck Foundation

  • MD Anderson submits plan to comply with Texas “Campus Carry” gun law 

  • The Cancer Letter’s coverage of power morcellation named a finalist in the 2015 Best in Business Awards for Outstanding Business Journalism
Drugs and Targets
  • FDA Approves Roche Hepatits C RNA Test

  • UPenn and Genisphere form photodynamic therapy collaboration

 

Copyright (c) 2020 The Cancer Letter Inc.